Ownership Submission
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
Kummeth Charles R.
   2. Issuer Name and Ticker or Trading Symbol
BIO-TECHNE Corp [TECH] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
Chief Executive Officer
(Last)
(First)
(Middle)
425 MARTINGALE ROAD, SUITE 2050		 3. Date of Earliest Transaction (Month/Day/Year)
10/26/2017
(Street)

SCHAUMBURG, IL 60173-2213		 4. If Amendment, Date Original Filed(Month/Day/Year)
 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)		 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/26/2017   A   14,194 A $ 0 84,472 (1) D  

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)		 6. Date Exercisable and Expiration Date
(Month/Day/Year)		 7. Title and Amount of Underlying Securities
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)		 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)		 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (2) 10/26/2017   A   21,291     (3)   (3) Common Stock 21,291 $ 0 21,291 D  
Stock Options (Right to buy) $ 125.05 10/26/2017   A   117,342     (3) 08/09/2024 Common Stock 117,342 $ 0 117,342 D  
Stock Options (Right to buy) $ 125.05 10/26/2017   A   78,228     (4) 08/09/2024 Common Stock 78,228 $ 0 78,228 D  
Restricted Stock Unit (2)               (5)   (5) Common Stock 17,283   17,283 D  
Restricted Stock Unit (2)               (6)   (6) Common Stock 24,979   24,979 D  
Stock Option (Right to Buy) $ 108.49               (7) 08/07/2022 Common Stock 79,517   79,517 D  
Stock Option (Right to Buy) $ 108.49               (5) 08/07/2022 Common Stock 119,275   119,275 D  
Stock Option (Right to Buy) $ 106.59               (8) 08/18/2023 Common Stock 102,779   102,779 D  
Stock Option (Right to Buy) $ 106.59               (6) 08/18/2023 Common Stock 154,169   154,169 D  
Stock Option (Right to Buy) $ 86.25               (9) 04/01/2021 Common Stock 46,316   46,316 D  
Stock Option (Right to Buy) $ 67.46               (10) 04/01/2020 Common Stock 65,000   65,000 D  
Stock Option (Right to Buy) $ 67.46               (10) 04/01/2020 Common Stock 50,000   50,000 D  
Stock Options (Right to buy) $ 94.35               (10) 08/12/2021 Common Stock 66,849   66,849 D  

Reporting Owners

Reporting Owner Name / Address Relationships
 Director  10% Owner  Officer  Other
Kummeth Charles R.
425 MARTINGALE ROAD
SUITE 2050
SCHAUMBURG, IL 60173-2213		       Chief Executive Officer  

Signatures

 /s/ Brenda S. Furlow, attorney in fact for Charles R. Kummeth pursuant to Power of Attorney filed here with   10/30/2017
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Includes (i) 10,203 shares for which the risk of forfeiture will lapse pursuant to achievement of performance goals; (ii) 3,841 shares for which the risks of forfeiture will lapse on August 7, 2018; and (iii) 11,102 shares for which the risks of forfeiture will lapse with respect to 5,551 shares on each of August 18, 2018 and August 18, 2019; and (iv) 4,731 shares each which risks of forfeiture will lapse on August 9, 2018 and August 9, 2019; and (v) 4,732 shares for which risks of forfeiture will lapse on August 9, 2020.
(2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
(3) Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(4) Vests 19,557 each on 8/9/2018, 8/9/2019, 8/9/2020, 8/9/2021
(5) Vests in full or in part on 8/7/18 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(6) Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
(7) 19,879 shares vest on each of August 7, 2016, August 7, 2017 and August 7, 2018 and 19,880 shares vest on August 7, 2019.
(8) Vests 25,695 shares on each of 8/18/17, 8/18/18, and 8/18/19 and 25,694 shares on 8/18/20.
(9) The option will vest pursuant to the following schedule: 5,790 shares on October 1, 2014, 965 shares on the first day of the month for the period beginning November 1, 2014 and ending March 1, 2018, and 961 shares on April 1, 2018.
(10) Fully exercisable

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.